123 related articles for article (PubMed ID: 20066899)
1. The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells.
Tallen G; Farhangi S; Tamannai M; Holtkamp N; Mangoldt D; Shah S; Suzuki K; Truss M; Henze G; Riabowol K; von Deimling A
Oncol Res; 2009; 18(2-3):95-105. PubMed ID: 20066899
[TBL] [Abstract][Full Text] [Related]
2. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G
Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.
Tallen UG; Truss M; Kunitz F; Wellmann S; Unryn B; Sinn B; Lass U; Krabbe S; Holtkamp N; Hagemeier C; Wurm R; Henze G; Riabowol KT; von Deimling A
J Neurooncol; 2008 Jan; 86(1):23-30. PubMed ID: 17763999
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
Brunckhorst MK; Wang H; Lu R; Yu Q
Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
[TBL] [Abstract][Full Text] [Related]
6. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.
Gong W; Russell M; Suzuki K; Riabowol K
Mol Cell Biol; 2006 Apr; 26(8):2947-54. PubMed ID: 16581770
[TBL] [Abstract][Full Text] [Related]
7. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.
Ceruti JM; Ogara MF; Menéndez C; Palmero I; Cánepa ET
Mol Cell Biochem; 2013 Jun; 378(1-2):117-26. PubMed ID: 23459830
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
10. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
11. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
[TBL] [Abstract][Full Text] [Related]
12. Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.
Coles AH; Liang H; Zhu Z; Marfella CG; Kang J; Imbalzano AN; Jones SN
Cancer Res; 2007 Mar; 67(5):2054-61. PubMed ID: 17332334
[TBL] [Abstract][Full Text] [Related]
13. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma.
Chen X; Du J; Zhu T
Pathol Biol (Paris); 2009 May; 57(3):e17-21. PubMed ID: 18450387
[TBL] [Abstract][Full Text] [Related]
14. The Hippo-TAZ axis mediates vascular endothelial growth factor C in glioblastoma-derived exosomes to promote angiogenesis.
Wang Z; Yuan Y; Ji X; Xiao X; Li Z; Yi X; Zhu Y; Guo T; Wang Y; Chen L; Liu Y
Cancer Lett; 2021 Aug; 513():1-13. PubMed ID: 34010715
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor p33ING1b upregulates p16INK4a expression and induces cellular senescence.
Li N; Li Q; Cao X; Zhao G; Xue L; Tong T
FEBS Lett; 2011 Oct; 585(19):3106-12. PubMed ID: 21896275
[TBL] [Abstract][Full Text] [Related]
16. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
17. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
[TBL] [Abstract][Full Text] [Related]
18. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
19. ING1a expression increases during replicative senescence and induces a senescent phenotype.
Soliman MA; Berardi P; Pastyryeva S; Bonnefin P; Feng X; Colina A; Young D; Riabowol K
Aging Cell; 2008 Dec; 7(6):783-94. PubMed ID: 18691180
[TBL] [Abstract][Full Text] [Related]
20. p33ING1b and estrogen receptor (ER) alpha.
Toyama T; Iwase H
Breast Cancer; 2004; 11(1):33-7. PubMed ID: 14718790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]